Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Surgery Partners (SGRY) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to $7.9 billion.

  • Surgery Partners' Liabilities and Shareholders Equity rose 547.09% to $7.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $31.7 billion, marking a year-over-year increase of 992.3%. This contributed to the annual value of $7.9 billion for FY2024, which is 1473.53% up from last year.
  • According to the latest figures from Q3 2025, Surgery Partners' Liabilities and Shareholders Equity is $7.9 billion, which was up 547.09% from $8.0 billion recorded in Q2 2025.
  • Surgery Partners' 5-year Liabilities and Shareholders Equity high stood at $8.0 billion for Q2 2025, and its period low was $5.6 billion during Q2 2021.
  • For the 5-year period, Surgery Partners' Liabilities and Shareholders Equity averaged around $6.8 billion, with its median value being $6.7 billion (2022).
  • In the last 5 years, Surgery Partners' Liabilities and Shareholders Equity soared by 1606.83% in 2022 and then soared by 291.23% in 2023.
  • Quarter analysis of 5 years shows Surgery Partners' Liabilities and Shareholders Equity stood at $6.1 billion in 2021, then rose by 9.23% to $6.7 billion in 2022, then grew by 2.91% to $6.9 billion in 2023, then grew by 14.74% to $7.9 billion in 2024, then increased by 0.72% to $7.9 billion in 2025.
  • Its Liabilities and Shareholders Equity was $7.9 billion in Q3 2025, compared to $8.0 billion in Q2 2025 and $7.9 billion in Q1 2025.